Ad

Read and Scott: 'We don't believe break-up of WPP makes sense'

Read and Scott: 'We don't believe break-up of WPP makes sense'

By

WPP's joint chief operating officers Mark Read and Andrew Scott have said they do not believe a break-up of the ad group makes sense.

Pro ad report 2017: Ad revenue plunged for print-first publishers

Pro ad report 2017: Ad revenue plunged for print-first publishers

The 2017 numbers aren't kind to print-first publishers. Is this a blip in print's fortunes or the start of a long-predicted decline?

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

By

Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?

DTC ads 2017: The good, the bad, and the ugly

DTC ads 2017: The good, the bad, and the ugly

By

We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.

McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

Pharma companies are likely to put up aggressive resistance to the measure, introduced earlier this month.

Five things for pharma marketers to know: Tuesday, August 29, 2017

Five things for pharma marketers to know: Tuesday, August 29, 2017

By

Drug ads make up to 38% of prime time commercials; Merck considers whether to pursue FDA approval for anacetrapib; BMS and Daiichi partner

PerfectLens sees ROI with programmatic ad buying

PerfectLens sees ROI with programmatic ad buying

By

The Canadian contact lens etailer partnered with a new technology vendor to look beyond its direct click-to-conversions.

Five things for pharma marketers to know: Friday, April 14, 2017

Five things for pharma marketers to know: Friday, April 14, 2017

By

Lawmaker wants better enforcement of TV ads placed by lawyers; more toddlers are taking antipsychotics; Neurocrine puts off price disclosure of new drug

How to Make DTC Ad 'Warnings' More Effective

How to Make DTC Ad 'Warnings' More Effective

A more general warning encourages consumers to engage in a personal discussion with their doctor about a drug, and it promotes engagement with longer-format printed or digitally-delivered information.